Trace amine-associated receptor 1 (TAAR1) is a widely recognized new perspective target for the neuropsychiatric pharmacological treatment. Despite a growing number of studies investigating TAAR1 role in the animal models of different pathologies, information of TAAR1 agonists impact on executive cognitive functions is limited. The goal of the present study was to evaluate the activity of highly selective partial TAAR1 agonist RO5263397 on various executive cognitive functions. The results of the present study demonstrated that the pretreatment with RO5263397 was able to increase attention and decrease cognitive flexibility in rats. The analysis of the RO5263397 action on impulsivity demonstrated that the TAAR1 activation failed to affect premature responding but was able to slightly modify impulsive choice. Problem solving was resistant to the pharmacological intervention.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Alvarsson A, Zhang X, Stan TL et al (2015) Modulation by trace amine-associated receptor 1 of experimental parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission. J Neurosci 35:14057–14069. https://doi.org/10.1523/JNEUROSCI.1312-15.2015
Asif-Malik A, Hoener MC, Canales JJ (2017) Interaction between the trace amine-associated receptor 1 and the dopamine D2 receptor controls cocaine’s neurochemical actions. Sci Rep 7:13901. https://doi.org/10.1038/s41598-017-14472-z
Berry MD, Gainetdinov RR, Hoener MC, Shahid M (2017) Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges. Pharmacol Ther 180:161–180. https://doi.org/10.1016/j.pharmthera.2017.07.002
Black SW, Schwartz MD, Chen T-M et al (2017) Trace amine-associated receptor 1 agonists as narcolepsy therapeutics. Biol Psychiatry 82:623–633. https://doi.org/10.1016/j.biopsych.2016.10.012
Borowsky B, Adham N, Jones KA et al (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci 98:8966–8971. https://doi.org/10.1073/pnas.151105198
Bräunig J, Dinter J, Höfig CS et al (2018) The trace amine-associated receptor 1 agonist 3-iodothyronamine induces biased signaling at the serotonin 1b receptor. Front Pharmacol 9:222. https://doi.org/10.3389/fphar.2018.00222
Bunzow JR, Sonders MS, Arttamangkul S et al (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181–1188
Cardinal RN, Robbins TW, Everitt BJ (2000) The effects of d-amphetamine, chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology 152:362–375. https://doi.org/10.1007/s002130000536
Cinque S, Zoratto F, Poleggi A et al (2018) Behavioral phenotyping of dopamine transporter knockout rats: compulsive traits, motor stereotypies, and anhedonia. Front Psychiatry 9:43. https://doi.org/10.3389/fpsyt.2018.00043
Cotter R, Pei Y, Mus L et al (2015) The trace amine-associated receptor 1 modulates methamphetamine’s neurochemical and behavioral effects. Front Neurosci 9:39. https://doi.org/10.3389/fnins.2015.00039
Dedic N, Jones PG, Hopkins SC et al (2019) SEP-363856, a novel psychotropic agent with a unique, non-D 2 receptor mechanism of action. J Pharmacol Exp Ther 371:1–14. https://doi.org/10.1124/jpet.119.260281
Di Cara B, Maggio R, Aloisi G et al (2011) Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). J Neurosci 31:16928–16940. https://doi.org/10.1523/JNEUROSCI.2502-11.2011
Espinoza S, Salahpour A, Masri B et al (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80:416–425. https://doi.org/10.1124/mol.111.073304
Espinoza S, Ghisi V, Emanuele M et al (2015a) Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology 93:308–313. https://doi.org/10.1016/j.neuropharm.2015.02.010
Espinoza S, Lignani G, Caffino L et al (2015b) TAAR1 modulates cortical glutamate NMDA receptor function. Neuropsychopharmacology 40:2217–2227. https://doi.org/10.1038/npp.2015.65
Evenden JL (1999) Varieties of impulsivity. Psychopharmacology 146:348–361. https://doi.org/10.1007/PL00005481
Ferragud A, Howell AD, Moore CF et al (2017) The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive, binge-like eating in rats. Neuropsychopharmacology 42:1458–1470. https://doi.org/10.1038/npp.2016.233
Gainetdinov RR, Hoener MC, Berry MD (2018) Trace amines and their receptors. Pharmacol Rev 70:549–620. https://doi.org/10.1124/pr.117.015305
Goonawardena AV, Morairty SR, Dell R et al (2019) Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques. Neuropsychopharmacology. https://doi.org/10.1038/s41386-019-0386-8
Henderson ND (1970) Behavioral reactions of Wistar rats to conditioned fear stimuli, novelty, and noxious stimulation. J Psychol 75:19–34. https://doi.org/10.1080/00223980.1970.9916801
Jahn-Eimermacher A, Lasarzik I, Raber J (2011) Statistical analysis of latency outcomes in behavioral experiments. Behav Brain Res 221:271–275. https://doi.org/10.1016/j.bbr.2011.03.007
Koblan K, Hopkins S, Justine K et al (2019) Efficacy and safety of SEP-363856, a novel psychotropic agent with a non-D2 mechanism of action, in the treatment of schizophrenia: a 4-week, randomized, placebo-controlled trial. Schizophr Bull 45:S199–S199. https://doi.org/10.1093/schbul/sbz021.269
Leo D, Sukhanov I, Zoratto F et al (2018) Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats. J Neurosci 38:1959–1972. https://doi.org/10.1523/JNEUROSCI.1931-17.2018
Lindemann L, Meyer CA, Jeanneau K et al (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324:948–956. https://doi.org/10.1124/jpet.107.132647
Liu J-F, Siemian JN, Seaman R et al (2017) Role of TAAR1 within the subregions of the mesocorticolimbic dopaminergic system in cocaine-seeking behavior. J Neurosci 37:882–892. https://doi.org/10.1111/j.1471-4159.1983.tb00893.x
Liu JF, Seaman R, Siemian JN et al (2018) Role of trace amine-associated receptor 1 in nicotine’s behavioral and neurochemical effects. Neuropsychopharmacology 43:2435–2444. https://doi.org/10.1038/s41386-018-0017-9
McGaughy J, Sarter M (1995) Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117:340–357
Motulsky HJ (2015) Common misconceptions about data analysis and statistics. Pharmacol Res Perspect 3:1–8. https://doi.org/10.1002/prp2.93
Pei Y, Mortas P, Hoener MC, Canales JJ (2015) Selective activation of the trace amine-associated receptor 1 decreases cocaine’s reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds. Prog Neuro-Psychopharmacol Biol Psychiatry 63:70–75. https://doi.org/10.1016/j.pnpbp.2015.05.014
Revel FG, Moreau J-L, Gainetdinov RR et al (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci 108:8485–8490. https://doi.org/10.1073/pnas.1103029108
Revel FG, Meyer CA, Bradaia A et al (2012a) Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37:2580–2592. https://doi.org/10.1038/npp.2012.109
Revel FG, Moreau JL, Gainetdinov RR et al (2012b) Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72:934–942. https://doi.org/10.1016/j.biopsych.2012.05.014
Revel FG, Moreau JL, Pouzet B et al (2013) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18:543–556. https://doi.org/10.1038/mp.2012.57
Rutigliano G, Accorroni A, Zucchi R (2018) The case for TAAR1 as a modulator of central nervous system function. Front Pharmacol 8:987. https://doi.org/10.3389/fphar.2017.00987
Schifani C, Sukhanov I, Dorofeikova M, Bespalov A (2017) Novel reinforcement learning paradigm based on response patterning under interval schedules of reinforcement. Behav Brain Res 331:276–281. https://doi.org/10.1016/j.bbr.2017.04.043
Schwartz MD, Black SW, Fisher SP et al (2017) Trace amine-associated receptor 1 regulates wakefulness and EEG spectral composition. Neuropsychopharmacology 42:1305–1314. https://doi.org/10.1038/npp.2016.216
Sukhanov I, Zakharova ES, Danysz W, Bespalov AY (2004) Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats. Behav Pharmacol 15:263–271. https://doi.org/10.1097/01.fbp.0000137212.03247.f1
Sukhanov I, Espinoza S, Yakovlev DS et al (2014) TAAR1-dependent effects of apomorphine in mice. Int J Neuropsychopharmacol 17:1683–1693. https://doi.org/10.1017/S1461145714000509
Sukhanov I, Dorofeikova M, Dolgorukova A et al (2018) Trace amine-associated receptor 1 modulates the locomotor and sensitization effects of nicotine. Front Pharmacol 9:329. https://doi.org/10.3389/fphar.2018.00329
Sukhanov I, Dorotenko A, Dolgorukova A et al (2019) Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2018.10.034
Sukhotina IA, Dravolina OA, Novitskaya Y et al (2008) Effects of mGlu1 receptor blockade on working memory, time estimation, and impulsivity in rats. Psychopharmacology 196:211–220. https://doi.org/10.1007/s00213-007-0953-2
Van Gaalen MM, Unger L, Jongen-Rêlo AL et al (2009) Amphetamine decreases behavioral inhibition by stimulation of dopamine D2, but not D3, receptors. Behav Pharmacol 20:484–491. https://doi.org/10.1097/FBP.0b013e3283305e3b
Wolinsky TD, Swanson CJ, Smith KE et al (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6:628–639. https://doi.org/10.1111/j.1601-183X.2006.00292.x
Xue Z, Siemian JN, Johnson BN et al (2018) Methamphetamine-induced impulsivity during chronic methamphetamine treatment in rats: effects of the TAAR 1 agonist RO5263397. Neuropharmacology 129:36–46. https://doi.org/10.1016/j.neuropharm.2017.11.012
Yates JR, Batten SR, Bardo MT, Beckmann JS (2015) Role of ionotropic glutamate receptors in delay and probability discounting in the rat. Psychopharmacology 232:1187–1196. https://doi.org/10.1007/s00213-014-3747-3
First of all, the authors would like to thank Dr Marius C. Hoener (F. Hoffmann-La Roche, Basel, Switzerland) for generous gift of compound RO5263397, Dr Mariia Dorofeikova for help in performing of OPBRS experiment, Dr Alexey I. Nevorotin, Dr Alexander Zhivich and Victor Zhivich for editing the manuscript as well as Dr Anton Bespalov for precious advices on the structure of Discussion section. The preliminary results of this study were presented at the 31st European College of Neuropsychopharmacology (ECNP) Congress (October 6–9, 2018, Barcelona, Spain) and published as the conference abstract in European Neuropsychopharmacology (2019, 29 (1S): S261–S262).
This study was supported by the Russian Science Foundation (Grant #17-75-20177).
Conflict of interest
All authors declared that they have no conflict of interest.
The First Pavlov State Saint Petersburg Medical University guideline for the care and use of animals was followed. Experimental protocols were approved by the Local Animal Care and Use Committee of First Pavlov State Saint Petersburg Medical University.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Chemical Compounds Studied in This Article: RO5263397.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Dorotenko, A., Tur, M., Dolgorukova, A. et al. The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats. Cell Mol Neurobiol 40, 215–228 (2020). https://doi.org/10.1007/s10571-019-00757-6
- Cognitive flexibility